| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 5 |
| NetGPI | no | yes: 0, no: 5 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005783 | endoplasmic reticulum | 5 | 2 |
| GO:0016020 | membrane | 2 | 5 |
| GO:0043226 | organelle | 2 | 2 |
| GO:0043227 | membrane-bounded organelle | 3 | 2 |
| GO:0043229 | intracellular organelle | 3 | 2 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: E9AFS9
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006629 | lipid metabolic process | 3 | 2 |
| GO:0006643 | membrane lipid metabolic process | 4 | 2 |
| GO:0006665 | sphingolipid metabolic process | 4 | 2 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
| GO:0008152 | metabolic process | 1 | 2 |
| GO:0009056 | catabolic process | 2 | 2 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0016042 | lipid catabolic process | 4 | 2 |
| GO:0030149 | sphingolipid catabolic process | 5 | 2 |
| GO:0044237 | cellular metabolic process | 2 | 2 |
| GO:0044238 | primary metabolic process | 2 | 2 |
| GO:0044242 | cellular lipid catabolic process | 4 | 2 |
| GO:0044248 | cellular catabolic process | 3 | 2 |
| GO:0044255 | cellular lipid metabolic process | 3 | 2 |
| GO:0046466 | membrane lipid catabolic process | 5 | 2 |
| GO:0046519 | sphingoid metabolic process | 5 | 2 |
| GO:0046521 | sphingoid catabolic process | 6 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 2 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
| GO:1901565 | organonitrogen compound catabolic process | 4 | 2 |
| GO:1901575 | organic substance catabolic process | 3 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 251 | 253 | PF00675 | 0.484 |
| CLV_NRD_NRD_1 | 56 | 58 | PF00675 | 0.408 |
| CLV_PCSK_KEX2_1 | 251 | 253 | PF00082 | 0.484 |
| CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.387 |
| CLV_PCSK_PC1ET2_1 | 69 | 71 | PF00082 | 0.387 |
| CLV_PCSK_SKI1_1 | 207 | 211 | PF00082 | 0.443 |
| CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.290 |
| DEG_SPOP_SBC_1 | 26 | 30 | PF00917 | 0.549 |
| DOC_CYCLIN_yCln2_LP_2 | 124 | 130 | PF00134 | 0.420 |
| DOC_MAPK_gen_1 | 69 | 77 | PF00069 | 0.447 |
| DOC_MAPK_MEF2A_6 | 142 | 150 | PF00069 | 0.447 |
| DOC_MAPK_MEF2A_6 | 70 | 79 | PF00069 | 0.447 |
| DOC_PP2B_LxvP_1 | 124 | 127 | PF13499 | 0.400 |
| DOC_USP7_MATH_1 | 235 | 239 | PF00917 | 0.673 |
| DOC_USP7_MATH_1 | 27 | 31 | PF00917 | 0.547 |
| DOC_USP7_UBL2_3 | 220 | 224 | PF12436 | 0.659 |
| LIG_14-3-3_CanoR_1 | 25 | 34 | PF00244 | 0.550 |
| LIG_14-3-3_CanoR_1 | 57 | 61 | PF00244 | 0.608 |
| LIG_Actin_WH2_2 | 43 | 59 | PF00022 | 0.470 |
| LIG_BRCT_BRCA1_1 | 58 | 62 | PF00533 | 0.608 |
| LIG_FHA_1 | 17 | 23 | PF00498 | 0.550 |
| LIG_FHA_1 | 2 | 8 | PF00498 | 0.559 |
| LIG_FHA_1 | 239 | 245 | PF00498 | 0.678 |
| LIG_FHA_1 | 95 | 101 | PF00498 | 0.362 |
| LIG_LIR_Gen_1 | 111 | 121 | PF02991 | 0.488 |
| LIG_LIR_Nem_3 | 107 | 112 | PF02991 | 0.275 |
| LIG_LIR_Nem_3 | 51 | 56 | PF02991 | 0.647 |
| LIG_LIR_Nem_3 | 59 | 63 | PF02991 | 0.514 |
| LIG_PAM2_1 | 25 | 37 | PF00658 | 0.549 |
| LIG_SH2_STAP1 | 110 | 114 | PF00017 | 0.502 |
| LIG_SH2_STAT5 | 110 | 113 | PF00017 | 0.303 |
| LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.564 |
| LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.558 |
| LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.494 |
| MOD_CK1_1 | 120 | 126 | PF00069 | 0.379 |
| MOD_CK1_1 | 16 | 22 | PF00069 | 0.555 |
| MOD_CK1_1 | 238 | 244 | PF00069 | 0.635 |
| MOD_CK1_1 | 9 | 15 | PF00069 | 0.579 |
| MOD_GlcNHglycan | 118 | 122 | PF01048 | 0.407 |
| MOD_GlcNHglycan | 235 | 238 | PF01048 | 0.431 |
| MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.345 |
| MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.372 |
| MOD_GSK3_1 | 100 | 107 | PF00069 | 0.228 |
| MOD_GSK3_1 | 233 | 240 | PF00069 | 0.668 |
| MOD_GSK3_1 | 25 | 32 | PF00069 | 0.529 |
| MOD_GSK3_1 | 82 | 89 | PF00069 | 0.357 |
| MOD_GSK3_1 | 9 | 16 | PF00069 | 0.568 |
| MOD_N-GLC_1 | 100 | 105 | PF02516 | 0.420 |
| MOD_NEK2_1 | 56 | 61 | PF00069 | 0.608 |
| MOD_NEK2_1 | 8 | 13 | PF00069 | 0.588 |
| MOD_PKA_1 | 233 | 239 | PF00069 | 0.636 |
| MOD_PKA_2 | 56 | 62 | PF00069 | 0.608 |
| MOD_Plk_1 | 100 | 106 | PF00069 | 0.420 |
| MOD_Plk_4 | 110 | 116 | PF00069 | 0.446 |
| MOD_Plk_4 | 120 | 126 | PF00069 | 0.277 |
| MOD_Plk_4 | 17 | 23 | PF00069 | 0.575 |
| MOD_Plk_4 | 56 | 62 | PF00069 | 0.537 |
| MOD_Plk_4 | 86 | 92 | PF00069 | 0.502 |
| MOD_SUMO_for_1 | 115 | 118 | PF00179 | 0.502 |
| MOD_SUMO_for_1 | 201 | 204 | PF00179 | 0.654 |
| TRG_DiLeu_BaEn_2 | 189 | 195 | PF01217 | 0.502 |
| TRG_ENDOCYTIC_2 | 125 | 128 | PF00928 | 0.475 |
| TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.608 |
| TRG_ER_diArg_1 | 250 | 252 | PF00400 | 0.680 |
| TRG_NES_CRM1_1 | 178 | 190 | PF08389 | 0.502 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3S7X9Y4 | Leishmania donovani | 92% | 100% |
| A4HNB9 | Leishmania braziliensis | 77% | 100% |
| A4IBZ2 | Leishmania infantum | 89% | 100% |
| E9B6Y1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
| O13737 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 100% |